Trial intelligence / Profile preview

Effectiveness of HIV preventive methods in Brazilian health services

RBR-2qfjpvPhase 4Not yet recruiting

Sponsor
Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo
Start
Sep 2015
Countries
1
01

Overview

Phase 4, open-label trial in human immunodeficiency virus infection (HIV) (5 arms), sponsored by Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo. Primary endpoint: Protective effect of sexual post-exposure prophylaxis. Planned start Sep 2015; status: not yet recruiting.

02

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on RBR-2qfjpv.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-2qfjpv.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call